A new vaccine provides hope for treating and even preventing the highly contagious and difficult-to-treat Clostridioides difficile infection, more commonly known as C. difficile or C. diff.

The portion of our nervous systems responsible for the "fight or flight" response can shape the severity of potentially deadly C. difficile infections, new research from the University of Virginia ...

OAKLAND, Calif. (AP) — OAKLAND, Calif. (AP) — Clorox Co. (CLX) on Wednesday reported fiscal first-quarter earnings of $99 million.

The ongoing trial is testing the therapy – RBX2660 – as a treatment for Clostridioides difficile infection or C. diff, a bacterium that causes diarrhoea and inflammation in the colon and is a ...

“C. diff is a really challenging pathogen,” said lead author Joseph Zackular, assistant professor of pathology and laboratory medicine at Penn. “This vaccine is kind of a really nice proof of ...

The product is based on purified Firmicutes bacterial spores delivered in an oral capsule that is designed to encourage the regrowth of healthy bacteria after antibiotic treatment for C.

Supported by world-class markets data from Dow Jones and FactSet, and partnering with Automated Insights, MarketWatch Automation brings you the latest, most pertinent content at record speed and ...